REGNANTE KEITH (Chief Financial Officer) sold 10.8% of their position (4.74K shares) of KEROS THERAPEUTICS, INC. on the open market
Open‑market sale worth $77.5K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/20/2026ACC: 0001682068-26-000003
Officer· Chief Financial Officer
Since Apr 2020
-4.74K
Net shares
Net seller
$77.5K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
4.74K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−4.74K
Price / share
$16.35
Trade value
$77.48K
% of position
10.8%
2/18/2026
44K→39.26K
Total
Net shares
−4.74K
Net value
-$77.48K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/18/2026 | S · Sale | −4.74K | $16.35 | $77.48K | 10.8% | 44K | 39.26K |
| Total | −4.74K | -$77.48K | ||||||
Derivative Transactions0
No derivative transactions reported